Grade D · no indexed studies3 peptides · 43 studies
Glow Stack (BPC-157 + TB-500 + GHK-Cu)
Healing | Tissue repair and inflammation modulation
This is a description, not a protocol to follow
Everything below is a summary of what people report doing and what the literature contains. Nothing here is medical advice.
What the evidence actually supports
Supported in animals
Animal-model studies indexed · 10
Cell and in-vitro studies indexed · 8
Reviews and uncategorised studies · 19
Not established
Any effect in humans · 6 human studies indexed
Any benefit from combining them · no combination study in our index
Human dose, route or duration · no PK study indexed
Protocol details
The Glow Stack protocol consists of BPC-157, TB-500, and GHK-Cu. However, published studies have not tested this specific combination of peptides together. The available research primarily focuses on the individual compounds.
BPC-157 has been investigated in various contexts, including its potential applications in orthopaedic and regenerative medicine. A systematic review indicated that while BPC-157 shows some anecdotal symptom improvement in small studies, the overall evidence remains weak and insufficient for clinical use outside of regulated trials [9]. Additionally, a review highlighted that BPC-157 demonstrates promise in rodent models for ischemia-reperfusion injury, but emphasized that the evidence is preliminary and requires further investigation before considering clinical use [11].
GHK-Cu has also been studied separately, with a review suggesting its potential as a therapeutic cargo, although current evidence does not support its clinical validation as a regenerative drug [10]. In an animal study, GHK-Cu was shown to achieve 99.8% wound closure in a murine model of antibiotic-resistant infection, but the applicability to human wounds remains unestablished [2]. Another review noted the need for well-designed human trials to assess the efficacy of GHK-Cu, particularly in topical microneedle delivery [12].
TB-500 was not included in the indexed studies, and therefore, no information is available regarding its effects or research findings. Overall, while individual studies on BPC-157 and GHK-Cu exist, there is no evidence supporting the efficacy or safety of the Glow Stack combination as a whole.
Sources
[2] Asymmetric-interfacial nanofibrous membranes with diode-like exudate transport for nanozyme-catalyzed antibacterial wound healing. — Biomaterials, 2026 https://doi.org/10.1016/j.biomaterials.2026.124483
[9] Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. — Acta orthopaedica Belgica, 2023 https://doi.org/10.52628/92.3.15837
[10] GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. — Pharmaceutics, 2026 https://doi.org/10.3390/pharmaceutics18091077
[11] BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence. — International journal of molecular sciences, 2020 https://doi.org/10.3390/ijms27188344
[12] A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. — Archives of internal medicine research, 2026 https://pubmed.ncbi.nlm.nih.gov/42787770/
Research & studies for this protocol
43 rows · showing 24Newest first
| Study | Compound | Source | Year |
|---|---|---|---|
| This narrative review evaluated the evidence, safety, and patient counseling regarding BPC-157 and other investigational peptides in orthopaedic practice. The review highlighted that BPC-157 has the largest body of direct musculoskeletal preclinical evidence, primarily from small-animal studies. However, human evidence is limited to one small retrospective uncontrolled case series. | BPC-157 | europepmc | 2023 |
| This systematic review evaluated the efficacy and safety of BPC-157 for orthopaedic and regenerative purposes in humans. Three studies with a total of 30 participants were included, reporting symptom improvement without treatment-related adverse events. However, the studies were of poor methodological quality. | BPC-157 | europepmc | 2023 |
| GHK-Cu and its effects on matrix remodeling, inflammation, and tissue repair were evaluated. The study conducted a systematic review of existing literature and clinical evidence. Findings indicate that while preclinical data support certain effects, clinical evidence remains sparse and lacks quality standards. | GHK-Cu | europepmc | 2026 |
| This critical review evaluates the preclinical evidence for BPC 157 in rodent ischemia-reperfusion injury (IRI) models, focusing on various biological responses. The review highlights the association of BPC 157 with oxidative injury attenuation and modulation of vascular responses. However, it emphasizes that the evidence is heterogeneous and preliminary. | BPC-157 | europepmc | 2020 |
| This systematic review evaluates the mechanisms and applications of GHK-Cu in topical microneedle delivery. The review synthesizes literature from 2005 to 2026, highlighting the lack of adequately powered human trials. It emphasizes the need for further clinical studies to validate preclinical findings. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 1980 |
| Not reported in abstract. | GHK-Cu | PubMed | 1996 |
| This systematic review evaluates the efficacy, safety, and regenerative mechanisms of GHK-Cu in aesthetic medicine. It included 20 studies, with 18 being preclinical and 2 randomized controlled trials (RCTs). The review found that GHK-Cu improved patient-reported satisfaction after laser resurfacing and significantly reduced wrinkle volume and depth compared with controls. | GHK-Cu | europepmc | 2026 |
| This review addresses the design challenges of bioabsorbable flow diverters (FDs) for intracranial aneurysm management. It examines how bioactive materials can balance scaffold resorption with aneurysm occlusion. The paper emphasizes the importance of material properties and design principles in enhancing device functionality. | GHK-Cu | europepmc | 2026 |
| This study developed a biomimetic nanoplatform targeting Alzheimer's disease, integrating multiple therapeutic bioactivities. In APP/PS1 transgenic mice, treatment resulted in reduced Aβ plaque deposition and improved cognitive functions. The study reports various in vitro and in vivo effects without making therapeutic claims. | GHK-Cu | europepmc | 2026 |
| This study measured the effects of systemic administration of tetrathiomolybdate (TTM) on collagen deposition and secretory function in irradiated mouse salivary glands. Mice received TTM in drinking water at a concentration of 0.1 mg/mL starting 7 days before and continuing through 7 days after a single 15-Gy dose of radiation therapy. The results indicated that TTM treatment improved stimulated saliva flow compared to control. | GHK-Cu | europepmc | 2026 |
| This study investigates asymmetric-interfacial Janus nanofibrous membranes for antibacterial wound healing in a murine model. The dressing achieved 99.8% wound closure by day 12 in infected wounds. The study highlights the membrane's ability to reduce bacterial burden and enhance healing without specific therapeutic claims. | GHK-Cu | europepmc | 2026 |
| A 72-year-old man experienced three episodes of cholangitis due to coil migration following treatment for a hepatic artery pseudoaneurysm. The patient underwent transcatheter arterial embolization with tornado microcoils. This case highlights the complications associated with coil migration into the bile duct. | BPC-157 | europepmc | 2023 |
| This study investigates the properties of a single layer of Bi2Sr2CuO6+δ (Bi-2201) to understand the effects of dimensionality reduction on superconductivity. The researchers found an approximately 10% reduction in the optimal superconducting transition temperature. The study explores the tunability of the material through controlled oxygenation. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| A fluorescent aptamer sensor based on a copper-based metal-organic framework was developed to monitor low-density lipoprotein (LDL) levels. The sensor demonstrated a linear range of 0.1-10,000 ng/mL and an ultra-low detection limit of 0.0789 ng/mL. It showed good accuracy and precision in human serum samples. | GHK-Cu | europepmc | 2026 |
| The study evaluated the structural and functional stability of Tachypleus gigas hemocyanin (TgH) across various temperatures and pH conditions. TgH retained 80% phenoloxidase activity up to 70 °C and demonstrated a melting temperature of 77.98 °C. The findings suggest potential applications in therapeutic and biotechnological fields. | GHK-Cu | europepmc | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| This study examined the impact of partially substituting inorganic zinc, copper, and manganese with organic forms in diets fed to gestating and lactating sows. A total of 344 sows and gilts were randomized to receive either the organic or inorganic mineral diets. Treated sows showed decreased lactation weight loss and odds of dew claw lesions compared to controls. | GHK-Cu | europepmc | 2026 |
| This paper evaluates the histopathological changes in an endosonographically created route (ESCR) following endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using a plastic stent in an 83-year-old man with perihilar cholangiocarcinoma. The patient underwent the procedure for recurrent biliary obstruction and died 141 days later, after which an autopsy was performed. The study reports on the fibrotic changes observed at the ESCR site. | BPC-157 | europepmc | 2023 |
| A 59-year-old Filipino man with long-standing unexplained iron-deficiency anemia was diagnosed with Necator americanus infection after gastrointestinal investigations. Image-enhanced endoscopy improved visualization of the parasites, leading to their identification and removal. Treatment with pyrantel pamoate resulted in symptom resolution and improved anemia. | BPC-157 | europepmc | 2023 |